Versameb AG, a preclinical stage company focused on the discovery and development of innovative RNA-based therapeutics, today announced that its Chief Scientific Officer, Friedrich Metzger, will present at the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) ...